Sym-006

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSym-006
Drug Alias Namerecombinant polyclonal antibody (Symphogen/Meiji Seika Kaisha)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSymphogen A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A